Literature DB >> 35860823

Femoropopliteal Bypasses with Varicose Great Saphenous Vein.

Sosei Kuma1,2, Kazuomi Iwasa1, Takuya Matsumoto2, Hideaki Uchiyama3.   

Abstract

The great saphenous vein is the conduit of choice for femoropopliteal or infrapopliteal bypass, but it is traditionally recommended that varicose vein grafts (VVGs) should not be used for bypass conduits owing to the risk of immediate rupture or long-term aneurysmal change. Herein, we report two cases of femoropopliteal bypass with VVGs. They achieved primary patency without aneurysmal formation after 32 and 17 months. Therefore, VVGs without morphologically conspicuous abnormalities are worth considering for usage as a vein graft.
© 2022 The Editorial Committee of Annals of Vascular Diseases.

Entities:  

Keywords:  long saphenous vein; peripheral arterial disease; varicose vein

Year:  2022        PMID: 35860823      PMCID: PMC9257389          DOI: 10.3400/avd.cr.21-00120

Source DB:  PubMed          Journal:  Ann Vasc Dis        ISSN: 1881-641X


  10 in total

1.  Femoropopliteal Bypass with Varicose Greater Saphenous Vein.

Authors:  Yun Su Mun; Byung Sun Cho; Je-Ho Jang; Moon-Soo Lee; Oh Sang Kwon
Journal:  Int J Angiol       Date:  2015-05-25

2.  2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteriesEndorsed by: the European Stroke Organization (ESO)The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS).

Authors:  Victor Aboyans; Jean-Baptiste Ricco; Marie-Louise E L Bartelink; Martin Björck; Marianne Brodmann; Tina Cohnert; Jean-Philippe Collet; Martin Czerny; Marco De Carlo; Sebastian Debus; Christine Espinola-Klein; Thomas Kahan; Serge Kownator; Lucia Mazzolai; A Ross Naylor; Marco Roffi; Joachim Röther; Muriel Sprynger; Michal Tendera; Gunnar Tepe; Maarit Venermo; Charalambos Vlachopoulos; Ileana Desormais
Journal:  Eur Heart J       Date:  2018-03-01       Impact factor: 29.983

3.  Classification and clinical impact of restenosis after femoropopliteal stenting.

Authors:  Atsushi Tosaka; Yoshimitsu Soga; Osamu Iida; Takayuki Ishihara; Keisuke Hirano; Kenji Suzuki; Hiroyoshi Yokoi; Shinsuke Nanto; Masakiyo Nobuyoshi
Journal:  J Am Coll Cardiol       Date:  2012-01-03       Impact factor: 24.094

4.  Prevalence of true vein graft aneurysms: implications for aneurysm pathogenesis.

Authors:  I M Loftus; M J McCarthy; A Lloyd; A R Naylor; P R Bell; M M Thompson
Journal:  J Vasc Surg       Date:  1999-03       Impact factor: 4.268

5.  Effects of vasoactive agents in healthy and diseased human saphenous veins.

Authors:  A Rizzi; D Quaglio; G Vasquez; F Mascoli; S Amadesi; G Calò; D Regoli; P Zamboni
Journal:  J Vasc Surg       Date:  1998-11       Impact factor: 4.268

6.  Infrainguinal aneurysm formation in arterialized autologous saphenous vein grafts.

Authors:  P C Cassina; S Hailemariam; R A Schmid; M Hauser
Journal:  J Vasc Surg       Date:  1998-11       Impact factor: 4.268

7.  Biochemical assay of collagen and elastin in the normal and varicose vein wall.

Authors:  M Venturi; L Bonavina; F Annoni; L Colombo; C Butera; A Peracchia; E Mussini
Journal:  J Surg Res       Date:  1996-01       Impact factor: 2.192

8.  External polytetrafluoroethylene reinforcement of varicose autologous vein grafts in peripheral bypass surgery produces durable bypass function.

Authors:  Achim Neufang; Christine Espinola-Klein; Savvas Savvidis; Walther Schmiedt; Alicia Poplawski; Christian Friedrich Vahl; Bernhard Dorweiler
Journal:  J Vasc Surg       Date:  2017-12-11       Impact factor: 4.268

9.  Distal bypass with a varicose vein graft for critical limb ischemia: report of a case.

Authors:  Atsushi Guntani; Ryosuke Yoshiga; Shinsuke Mii
Journal:  Surg Case Rep       Date:  2019-12-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.